The MarketReader Minute
đź’Š Biotech ETF Rises on Global Regulatory Wins and Retail Sales Beat | Biotech Sector Insights
(IBB) rose 0.8% as positive regulatory developments and supportive macro data boosted sector sentiment. ImmunityBio’s ANKTIVA received approval from the Saudi Food and Drug Authority. Gains among major holdings, including Gilead, Amgen, Moderna, Incyte, and Sarepta, further supported the ETF.